Short Interest in Nutex Health Inc. (NASDAQ:NUTX) Increases By 25.5%

Key Points

• Nutex Health Inc. saw a substantial increase in short interest, rising by 25.5% to 1,120,000 shares as of August 31st, representing approximately 31.6% of its total shares.
• The company's stock price opened at $89.98, with a market capitalization of $500.29 million and a P/E ratio of 7.57.
• Analysts have mixed views on the stock; while Maxim Group set a price target of $205.00 and a "buy" rating, Wall Street Zen downgraded it to a "hold," reflecting a range of sentiments among investors.

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) saw a significant increase in short interest during the month of August. As of August 31st, there was short interest totaling 1,120,000 shares, an increase of 25.5% from the August 15th total of 892,100 shares. Currently, 31.6% of the company's stock are sold short. Based on an average daily trading volume, of 247,800 shares, the short-interest ratio is currently 4.5 days. Based on an average daily trading volume, of 247,800 shares, the short-interest ratio is currently 4.5 days. Currently, 31.6% of the company's stock are sold short.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on NUTX. Wall Street Zen downgraded Nutex Health from a "buy" rating to a "hold" rating in a research note on Saturday, September 13th. Maxim Group set a $205.00 price target on Nutex Health and gave the stock a "buy" rating in a report on Tuesday, August 26th. Two equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $252.50.

Institutional Trading of Nutex Health

Several institutional investors and hedge funds have recently bought and sold shares of NUTX. Topline Capital Management LLC grew its position in shares of Nutex Health by 72.0% during the 2nd quarter. Topline Capital Management LLC now owns 309,131 shares of the company's stock valued at $38,484,000 after purchasing an additional 129,418 shares in the last quarter. American Century Companies Inc. boosted its stake in Nutex Health by 39.9% during the second quarter. American Century Companies Inc. now owns 104,063 shares of the company's stock valued at $12,955,000 after buying an additional 29,704 shares during the period. Marshall Wace LLP grew its position in Nutex Health by 333.4% during the second quarter. Marshall Wace LLP now owns 94,548 shares of the company's stock worth $11,770,000 after buying an additional 72,734 shares in the last quarter. Geode Capital Management LLC increased its stake in Nutex Health by 116.8% in the 2nd quarter. Geode Capital Management LLC now owns 78,859 shares of the company's stock worth $9,819,000 after acquiring an additional 42,484 shares during the last quarter. Finally, Divisadero Street Capital Management LP bought a new position in Nutex Health in the 2nd quarter worth about $7,481,000. 5.32% of the stock is currently owned by hedge funds and other institutional investors.

Nutex Health Stock Performance

Nutex Health stock traded up $3.15 during midday trading on Friday, reaching $96.11. The stock had a trading volume of 272,699 shares, compared to its average volume of 152,976. The firm has a market capitalization of $534.37 million, a PE ratio of 8.08 and a beta of -0.17. Nutex Health has a 12 month low of $17.51 and a 12 month high of $184.27. The company has a quick ratio of 2.26, a current ratio of 2.27 and a debt-to-equity ratio of 1.02. The firm's 50-day moving average price is $93.62 and its 200 day moving average price is $105.64.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.